Choice of and response to treatment in patients with early-diagnosed rheumatoid arthritis: Real-world data from an inception cohort in Japan (NICER-J).
暂无分享,去创建一个
H. Ishikawa | H. Wakabayashi | A. Kaneko | M. Kojima | T. Kojima | N. Takahashi | S. Asai | Y. Yoshioka | K. Terabe | S. Imagama | Y. Takakubo | S. Tsuji | T. Okano | Y. Hirano | Y. Nasu | Hideo Sakane | E. Torikai | Satomi Nagamine | Tatsuo Watanabe | Y. Sobue | T. Fujibayashi | Mochihito Suzuki | H. Takagi | R. Hara | K. Hattori | T. Kaneko | Y. Yokota | K. Kishimoto | D. Kihira | T. Kato | T. Takemoto | Tsuyoshi Nishiume | Y. Ohashi | Toshifumi Fujiwara
[1] N. Miyasaka,et al. Effectiveness and safety of treat-to-target strategy in elderly-onset rheumatoid arthritis: a 3-year prospective observational study. , 2021, Rheumatology.
[2] D. Solomon,et al. Achievement of Remission in Two Early Rheumatoid Arthritis Cohorts Implementing Different Treat‐to‐Target Strategies , 2020, Arthritis & rheumatology.
[3] Tsutomu Takeuchi,et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update , 2020, Annals of the Rheumatic Diseases.
[4] I. Haugen,et al. Swollen, but not tender joints, are independently associated with ultrasound synovitis: results from a longitudinal observational study of patients with established rheumatoid arthritis , 2019, Annals of the rheumatic diseases.
[5] E. Soriano,et al. Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort , 2019, Clinical Rheumatology.
[6] T. Kvien,et al. Treat to target strategy in early rheumatoid arthritis versus routine care - A comparative clinical practice study. , 2019, Seminars in arthritis and rheumatism.
[7] T. Tomita,et al. Japan College of Rheumatology guideline for the use of methotrexate in patients with rheumatoid arthritis , 2019, Modern rheumatology.
[8] T. Mimori,et al. Elderly onset of early rheumatoid arthritis is a risk factor for bone erosions, refractory to treatment: KURAMA cohort , 2018, International journal of rheumatic diseases.
[9] Charles King,et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis , 2016, Arthritis & rheumatology.
[10] E. Keystone,et al. Physician global assessment at 3 months is strongly predictive of remission at 12 months in early rheumatoid arthritis: results from the CATCH cohort. , 2014, Rheumatology.
[11] David T Felson,et al. UvA-DARE (Digital Academic Repository) American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials , 2011 .
[12] S. Saevarsdottir,et al. Predictors of response to methotrexate in early DMARD naïve rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial , 2010, Annals of the rheumatic diseases.
[13] A. Silman,et al. Rheumatoid arthritis classifi cation criteria : an American College of Rheumatology / European League Against Rheumatism collaborative initiative , 2010 .
[14] Maurizio Cutolo,et al. Treating rheumatoid arthritis to target: recommendations of an international task force , 2010, Annals of the rheumatic diseases.
[15] D. M. van der Heijde,et al. Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade , 2008, Annals of the rheumatic diseases.
[16] K. Ikari,et al. Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year outcome of joint destruction (RECONFIRM-2J) , 2008, Modern rheumatology.
[17] M. Uffmann,et al. Patients and Methods , 2022 .
[18] James M Robins,et al. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study , 2002, The Lancet.
[19] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.
[20] G. Jones,et al. The effect of treatment on radiological progression in rheumatoid arthritis: a systematic review of randomized placebo-controlled trials. , 2003, Rheumatology.
[21] J J Anderson,et al. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. , 2000, Arthritis and rheumatism.